ICU Medical, Inc.
ICUI
$133.31
$2.001.52%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -10.88% | -6.33% | -0.84% | 2.96% | 7.22% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.88% | -6.33% | -0.84% | 2.96% | 7.22% |
| Cost of Revenue | -14.76% | -9.51% | -6.17% | -2.18% | 3.04% |
| Gross Profit | -3.71% | -0.33% | 10.04% | 13.65% | 15.90% |
| SG&A Expenses | -2.47% | -2.12% | -0.99% | 2.86% | 4.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.97% | -7.12% | -4.50% | -0.71% | 3.40% |
| Operating Income | -9.17% | 12.25% | 181.65% | 214.95% | 257.94% |
| Income Before Tax | 123.64% | 104.80% | 126.84% | 116.17% | 60.51% |
| Income Tax Expenses | -168.82% | -95.28% | 38,183.51% | 291.74% | 226.39% |
| Earnings from Continuing Operations | 149.46% | 100.62% | 93.37% | 47.80% | -57.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 149.46% | 100.62% | 93.37% | 47.80% | -57.96% |
| EBIT | -9.17% | 12.25% | 181.65% | 214.95% | 257.94% |
| EBITDA | -6.94% | -2.16% | 23.23% | 24.75% | 27.53% |
| EPS Basic | 148.97% | 100.59% | 93.27% | 47.92% | -56.19% |
| Normalized Basic EPS | 115.54% | 384.65% | 168.34% | 142.45% | 122.03% |
| EPS Diluted | 148.22% | 100.45% | 92.95% | 47.54% | -56.62% |
| Normalized Diluted EPS | 114.13% | 384.38% | 168.30% | 142.49% | 122.07% |
| Average Basic Shares Outstanding | 0.94% | 1.04% | 1.20% | 1.27% | 1.34% |
| Average Diluted Shares Outstanding | 1.43% | 1.10% | 1.27% | 1.09% | 1.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |